Wall Street Turns Bullish on Capricor as FDA Extends Review for Deramiocel to November
Oppenheimer raises Capricor to Outperform on clearer path for deramiocel. $54 target, PDUFA Nov 22 after upper-limb focus.
NOTRELOAD AI
Dick’s Sporting Goods Shares Plunge After Cutting Full-Year Outlook on Weak Athletic Demand
Dick’s reported weaker-than-expected Q2 results and reduced its full-year forecast as cautious consumers weighed on sporting goods sales.
Fluence Energy Gets UBS Upgrade: Stock Now Seen as Fairly Valued
2026 guidance cut sets a near-term earnings trough, creating a favorable base for 2027 growth reacceleration.
Nayax to Acquire IPS Group for $350 Million, Expanding Smart Parking Footprint
Deal expands smart parking leadership and cashless market by $85B, reaching $342B by 2029.
Wolfe Research Upgrades Moderna to Peer Perform After Cancer Vaccine Breakthrough
Wolfe Research upgrades Moderna to Peer Perform following Phase 3 intismeran success and a potential $9.2 billion peak sales outlook.
Raymond James Lifts AMD Price Target to $641, Forecasts $201 Billion Revenue by 2030
Raymond James upgrades AMD to Strong Buy, citing 44% annual growth and $201 billion in revenue by 2030, implying ~40% upside.